XYLOCARD 20 mg/ml INTRAVEINEUX, solution injectable

Business Listing - September 04, 2021

XYLOCARD 20 mg/ml INTRAVEINEUX, solution injectable

XYLOCARD 20 mg/ml INTRAVEINEUX, solution injectable solution injectable intraveineuse Autorisation active Procédure nationale Commercialisée 6/20/1986 ASPEN PHARMA TRADING (IRLANDE)

Tags & Categories

intraveineuse active solution injectable autorisation procédure commercialisée nationale intraveineux xylocard

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business